mRNA |
LE-135 |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.01 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.01 |
mRNA |
QL-XI-92 |
GDSC1000 |
pan-cancer |
AAC |
-0.076 |
0.01 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.01 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.01 |
mRNA |
tandutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.01 |
mRNA |
AA-COCF3 |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.01 |
mRNA |
lapatinib |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.01 |
mRNA |
SB52334 |
GDSC1000 |
pan-cancer |
AAC |
-0.08 |
0.02 |
mRNA |
WZ3105 |
GDSC1000 |
pan-cancer |
AAC |
-0.072 |
0.02 |